These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
246 related articles for article (PubMed ID: 24091482)
1. Daily step count is associated with plasma C-reactive protein and IL-6 in a US cohort with COPD. Moy ML; Teylan M; Weston NA; Gagnon DR; Danilack VA; Garshick E Chest; 2014 Mar; 145(3):542-550. PubMed ID: 24091482 [TBL] [Abstract][Full Text] [Related]
2. An index of daily step count and systemic inflammation predicts clinical outcomes in chronic obstructive pulmonary disease. Moy ML; Teylan M; Danilack VA; Gagnon DR; Garshick E Ann Am Thorac Soc; 2014 Feb; 11(2):149-57. PubMed ID: 24308588 [TBL] [Abstract][Full Text] [Related]
3. Systemic inflammation in patients with COPD and pulmonary hypertension. Joppa P; Petrasova D; Stancak B; Tkacova R Chest; 2006 Aug; 130(2):326-33. PubMed ID: 16899829 [TBL] [Abstract][Full Text] [Related]
4. Six-minute-walk distance and accelerometry predict outcomes in chronic obstructive pulmonary disease independent of Global Initiative for Chronic Obstructive Lung Disease 2011 Group. Durheim MT; Smith PJ; Babyak MA; Mabe SK; Martinu T; Welty-Wolf KE; Emery CF; Palmer SM; Blumenthal JA Ann Am Thorac Soc; 2015 Mar; 12(3):349-56. PubMed ID: 25568929 [TBL] [Abstract][Full Text] [Related]
5. Reasons persons with COPD do not walk and relationship with daily step count. Danilack VA; Weston NA; Richardson CR; Mori DL; Moy ML COPD; 2014 Jun; 11(3):290-9. PubMed ID: 24152213 [TBL] [Abstract][Full Text] [Related]
6. Daily step count predicts acute exacerbations in a US cohort with COPD. Moy ML; Teylan M; Weston NA; Gagnon DR; Garshick E PLoS One; 2013; 8(4):e60400. PubMed ID: 23593211 [TBL] [Abstract][Full Text] [Related]
7. Physical Activity in Overlap Syndrome of COPD and Obstructive Sleep Apnea: Relationship With Markers of Systemic Inflammation. Fitzgibbons CM; Goldstein RL; Gottlieb DJ; Moy ML J Clin Sleep Med; 2019 Jul; 15(7):973-978. PubMed ID: 31383234 [TBL] [Abstract][Full Text] [Related]
8. Inflammatory markers and circulating extracellular matrix proteins in patients with chronic obstructive pulmonary disease and left ventricular diastolic dysfunction. López-Sánchez M; Muñoz-Esquerre M; Huertas D; Montes A; Molina-Molina M; Manresa F; Dorca J; Santos S Clin Respir J; 2017 Nov; 11(6):859-866. PubMed ID: 26663885 [TBL] [Abstract][Full Text] [Related]
9. [Systemic inflammation among stable ex smokers with chronic obstructive pulmonary disease]. Morales S A; Dreyse D J; Díaz P O; Saldías P F; Carrasco M; Lisboa B C Rev Med Chil; 2010 Aug; 138(8):957-64. PubMed ID: 21140052 [TBL] [Abstract][Full Text] [Related]
10. Raised CRP levels mark metabolic and functional impairment in advanced COPD. Broekhuizen R; Wouters EF; Creutzberg EC; Schols AM Thorax; 2006 Jan; 61(1):17-22. PubMed ID: 16055618 [TBL] [Abstract][Full Text] [Related]
11. Inflammatory biomarkers and exacerbations in chronic obstructive pulmonary disease. Thomsen M; Ingebrigtsen TS; Marott JL; Dahl M; Lange P; Vestbo J; Nordestgaard BG JAMA; 2013 Jun; 309(22):2353-61. PubMed ID: 23757083 [TBL] [Abstract][Full Text] [Related]
12. Is the COPD assessment test (CAT) effective in demonstrating the systemic inflammation and other components in COPD? Sarioglu N; Hismiogullari AA; Bilen C; Erel F Rev Port Pneumol (2006); 2016; 22(1):11-7. PubMed ID: 26534740 [TBL] [Abstract][Full Text] [Related]
13. C-reactive protein in patients with COPD, control smokers and non-smokers. Pinto-Plata VM; Müllerova H; Toso JF; Feudjo-Tepie M; Soriano JB; Vessey RS; Celli BR Thorax; 2006 Jan; 61(1):23-8. PubMed ID: 16143583 [TBL] [Abstract][Full Text] [Related]
14. Three-year follow-up of Interleukin 6 and C-reactive protein in chronic obstructive pulmonary disease. Ferrari R; Tanni SE; Caram LM; Corrêa C; Corrêa CR; Godoy I Respir Res; 2013 Feb; 14(1):24. PubMed ID: 23425215 [TBL] [Abstract][Full Text] [Related]
15. [Correlation among the levels of C-reactive protein and interleukin-18, quality of life, and lung function in patients with chronic obstructive pulmonary disease]. Long H; Luo H; Chen P; Li Y Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2011 Nov; 36(11):1090-6. PubMed ID: 22169727 [TBL] [Abstract][Full Text] [Related]
16. Heart Rate Recovery, Physical Activity Level, and Functional Status in Subjects With COPD. Morita AA; Silva LKO; Bisca GW; Oliveira JM; Hernandes NA; Pitta F; Furlanetto KC Respir Care; 2018 Aug; 63(8):1002-1008. PubMed ID: 29765005 [TBL] [Abstract][Full Text] [Related]
17. Plasma leptin and adiponectin in COPD exacerbations: associations with inflammatory biomarkers. Krommidas G; Kostikas K; Papatheodorou G; Koutsokera A; Gourgoulianis KI; Roussos C; Koulouris NG; Loukides S Respir Med; 2010 Jan; 104(1):40-6. PubMed ID: 19782551 [TBL] [Abstract][Full Text] [Related]
18. C-reactive protein levels in stable COPD patients: a case-control study. Silva DR; Gazzana MB; Knorst MM Int J Chron Obstruct Pulmon Dis; 2015; 10():1719-25. PubMed ID: 26357470 [TBL] [Abstract][Full Text] [Related]
19. Echocardiographic Evaluation of the Relationship Between inflammatory factors (IL6, TNFα, hs-CRP) and Secondary Pulmonary Hypertension in patients with COPD. A Cross sectional study. Ansarin K; Rashidi F; Namdar H; Ghaffari M; Sharifi A Pneumologia; 2015; 64(3):31-5. PubMed ID: 26738368 [TBL] [Abstract][Full Text] [Related]
20. Proteasome activity related with the daily physical activity of COPD patients. Lee KY; Chen TT; Chiang LL; Chuang HC; Feng PH; Liu WT; Chen KY; Ho SC Int J Chron Obstruct Pulmon Dis; 2017; 12():1519-1525. PubMed ID: 28579770 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]